Who invested in Artielle ImmunoTherapeutics?
Artielle ImmunoTherapeutics's investors include Pelion Venture Partners, Sanderling Ventures, Tenex Greenhouse Ventures and Northwest Technology Ventures.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$186Kraised across 2 rounds since 2004, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $186K sold, first sale Feb 2010
From a historical funding record
From Artielle ImmunoTherapeutics's own website and the SEC filings it signed: 4 on the team.
On the board, as filediAllan N. WolfeJ. Brock MetcalfPaul N. QuadrosShahab N. Fatheazam
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Artielle ImmunoTherapeutics's investors include Pelion Venture Partners, Sanderling Ventures, Tenex Greenhouse Ventures and Northwest Technology Ventures.
Artielle ImmunoTherapeutics has raised $186K across 2 rounds since 2004. One round did not disclose an amount, so the total is a floor.
Artielle ImmunoTherapeutics's most recent round was an Undisclosed round of $186K in Apr 2010.
Its most recent round, $186K in Apr 2010, is also its largest on record.
Artielle ImmunoTherapeutics's first round on record, in Jun 2004, was backed by Pelion Venture Partners, Sanderling Ventures and Tenex Greenhouse Ventures and 1 others.
Artielle ImmunoTherapeutics's latest named round is an Undisclosed round, in Apr 2010.
Artielle ImmunoTherapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.